Read more cancer drug stories on Newserhttp://www.newser.com/taggrid/40791/cancer-drug.html2009 - Newseren-usNewser Feed GeneratorTue, 24 Nov 2009 9:24:27 CSThttp://www.newser.com/story/73859/scientists-disarm-cancer-protein.html?utm_source=syn&utm_medium=rss&utm_campaign=tagScientists believe they have found a way to neutralize a protein involved in cancer formation that was previously considered "undruggable." The researchers, experimenting on mice, created chemical "staples" to mold snippets of protein into shapes capable of disrupting the protein's function. The protein is linked to runaway cell growth in...http://www.newser.com/story/73859/scientists-disarm-cancer-protein.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 12 Nov 2009 1:45:59 CSThttp://www.newser.com/story/68374/drug-giants-target-cancer.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMajor drug companies are tying their fortunes to cancer like never before, the New York Times reports. The firms—inspired by advancements in science as well as the high prices cancer drugs command—are pouring unprecedented resources into the search for new cancer drugs. The drug giants hope cancer treatments...http://www.newser.com/story/68374/drug-giants-target-cancer.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 02 Sep 2009 2:16:47 CDThttp://www.newser.com/story/65973/dearth-of-patient-volunteers-cripples-cancer-research.html?utm_source=syn&utm_medium=rss&utm_campaign=tagCancer death rates have changed little in the past 40 years, and one big reason often goes unremarked on, experts say: only 3% of adult cancer patients participate in studies of treatments, the New York Times reports. More than a fifth of trials sponsored by the National Cancer Institute couldn’t...http://www.newser.com/story/65973/dearth-of-patient-volunteers-cripples-cancer-research.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMon, 03 Aug 2009 11:38:31 CDThttp://www.newser.com/story/63038/why-cancer-researchers-are-playing-it-safe.html?utm_source=syn&utm_medium=rss&utm_campaign=tagIf you're a cancer researcher, it's harder to get money to investigate a potentially field-changing question than to find out whether a food's tastiness affects dieting. The reason is simple but problematic: With limited funding available and lots of research to do, grant-givers don't want to lose money on a...http://www.newser.com/story/63038/why-cancer-researchers-are-playing-it-safe.html?utm_source=syn&utm_medium=rss&utm_campaign=tagSun, 28 Jun 2009 12:40:30 CDThttp://www.newser.com/story/62776/new-class-of-drugs-could-revolutionize-cancer-treatment.html?utm_source=syn&utm_medium=rss&utm_campaign=tagA new class of drugs in development represents the biggest cancer breakthrough in a decade, Robert Bazell writes at NBC. In a study causing much excitement in the medical world, breast, ovarian, and prostate cancer patients treated with Olaparib, one of a group of drugs known as PARP inhibitors, had...http://www.newser.com/story/62776/new-class-of-drugs-could-revolutionize-cancer-treatment.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 25 Jun 2009 9:12:01 CDThttp://www.newser.com/story/60727/drug-shows-hope-for-advanced-skin-cancer.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMore promising news has emerged from this weekend’s international cancer conference in Florida: Researchers unveiled a drug that shows early promise in fighting the most deadly form of skin cancer. The experimental PLX4032 targets tumor cells that carry a mutation found in 60% of malignant melanomas, and in the 16...http://www.newser.com/story/60727/drug-shows-hope-for-advanced-skin-cancer.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMon, 01 Jun 2009 22:56:25 CDThttp://www.newser.com/story/60634/drug-offers-hope-for-genetic-breast-cancer-sufferers.html?utm_source=syn&utm_medium=rss&utm_campaign=tagA first-of-its-kind drug has been developed to fight genetic breast cancer, with an initial round of human trials showing “very promising” results, reports the Times of London. The drug Olaparib works by blocking a protein that makes cancer cells containing the genetic default unable to repair themselves. The drug shrank...http://www.newser.com/story/60634/drug-offers-hope-for-genetic-breast-cancer-sufferers.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMon, 01 Jun 2009 8:31:46 CDThttp://www.newser.com/story/60258/man-without-prints-stumps-airport-security.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThe side effects of a drug to treat cancer led to a Singapore man being detained for hours by airport security officials who couldn’t find his fingerprints, USA Today reports. The drug capecitabine causes hand-foot syndrome, in which the skin peels off; the man was finally allowed through after being...http://www.newser.com/story/60258/man-without-prints-stumps-airport-security.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 27 May 2009 16:42:02 CDThttp://www.newser.com/story/59838/happyhour-gene-decides-how-fast-you-get-drunk.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWhat if your genes determined how much of a tolerance you had to alcohol—and you could take a drug that would turn those genes on or off? That scenario may not be far from reality: researchers studying fruit flies have discovered a gene called "happyhour" that renders heavyweights incapable...http://www.newser.com/story/59838/happyhour-gene-decides-how-fast-you-get-drunk.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFri, 22 May 2009 11:15:02 CDT